Bioextrax AB (85X0) Stock Statistics & Valuation Metrics
Total Valuation
Bioextrax AB has a market cap or net worth of EUR 10.39M. The enterprise value is EUR 109.23M.
- Market Cap
- EUR 10.39M
- Enterprise Value
- EUR 109.23M
Share Statistics
Bioextrax AB has 49,364,758 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 49,364,758
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Bioextrax AB’s return on equity (ROE) is -0.83 and return on invested capital (ROIC) is -86.58%.
- Return on Equity (ROE)
- -0.83
- Return on Assets (ROA)
- -0.72
- Return on Invested Capital (ROIC)
- -86.58%
- Return on Capital Employed (ROCE)
- -0.87
- Revenue Per Employee
- 54.07K
- Profits Per Employee
- -1.26M
- Employee Count
- 14
- Asset Turnover
- 0.03
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Bioextrax AB is -5.41. Bioextrax AB’s PEG ratio is 17.07.
- PE Ratio
- -5.41
- PS Ratio
- 205.53
- PB Ratio
- 9.34
- Price to FCF
- -4.44
- Price to Operating Cash Flow
- -4.48
- PEG Ratio
- 17.07
Income Statement
In the last 12 months, Bioextrax AB had revenue of 757.00K and earned -17.70M in profits. Earnings per share was -0.45.
- Revenue
- 757.00K
- Gross Profit
- -16.43M
- Operating Income
- -18.37M
- Pretax Income
- -17.70M
- Net Income
- -17.70M
- EBITDA
- -17.24M
- Earnings Per Share (EPS)
- -0.45
Cash Flow
In the last 12 months, operating cash flow was -23.34M and capital expenditures -277,000, giving a free cash flow of -23.61M billion.
- Operating Cash Flow
- -23.34M
- Free Cash Flow
- -23.61M
- Free Cash Flow per Share
- -0.53
Dividends & Yields
Bioextrax AB pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -22.53%
- Earnings Yield
- -16.60%
Stock Price Statistics
- Beta
- 0.78
- 52-Week Price Change
- 3.00%
- 50-Day Moving Average
- 0.20
- 200-Day Moving Average
- 0.22
- Relative Strength Index (RSI)
- 60.54
- Average Volume (3m)
- ―
Important Dates
Bioextrax AB upcoming earnings date is Nov 20, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 21, 2026
- Next Earnings Date
- Nov 20, 2026
- Ex-Dividend Date
- ―
Financial Position
Bioextrax AB as a current ratio of 1.58, with Debt / Equity ratio of 0.00%
- Current Ratio
- 1.58
- Quick Ratio
- 1.58
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.23
- Interest Coverage Ratio
- -18368.00
Taxes
In the past 12 months, Bioextrax AB has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Bioextrax AB EV to EBITDA ratio is -5.72, with an EV/FCF ratio of -4.15.
- EV to Sales
- 191.97
- EV to EBITDA
- -5.72
- EV to Free Cash Flow
- -4.15
- EV to Operating Cash Flow
- -4.19
Balance Sheet
Bioextrax AB has EUR 7.39M in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 7.39M billion.
- Cash & Marketable Securities
- EUR 7.39M
- Total Debt
- EUR 0.00
- Net Cash
- EUR 7.39M
- Net Cash Per Share
- EUR 0.15
- Tangible Book Value Per Share
- EUR 0.25
Margins
Gross margin is -3524.04%, with operating margin of -3524.04%, and net profit margin of -3407.52%.
- Gross Margin
- -3524.04%
- Operating Margin
- -3524.04%
- Pretax Margin
- -3407.52%
- Net Profit Margin
- -3407.52%
- EBITDA Margin
- -3353.94%
- EBIT Margin
- -3495.60%
Analyst Forecast
The average price target for Bioextrax AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -36.00%
- EPS Growth Forecast
- -2.34%
